Literature DB >> 1352876

Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.

M You1, Y Wang, G Stoner, L You, R Maronpot, S H Reynolds, M Anderson.   

Abstract

A mouse strain with low lung tumor susceptibility (C3H) and a strain with high lung tumor susceptibility (A/J) were reciprocally crossed to produce C3A and AC3 F1 hybrid mice. Ki-ras oncogenes were detected in spontaneous and chemically induced lung tumors obtained from the C3A and AC3 mice. To further explore the genetics of the Ki-ras gene in mouse lung tumor susceptibility, the parental origin of Ki-ras oncogenes detected in lung tumors from the F1 hybrids was determined by a strategy based on a 37-base-pair deletion in the second intron of the A/J Ki-ras allele. Ki-ras oncogenes were derived from the A/J parent in 38 of 40 tumors obtained from C3A mice and 30 of 30 tumors from AC3 mice. The observation that the activated oncogene in hybrids originates from the susceptible parent suggests that the Ki-ras gene is directly linked to mouse lung tumor susceptibility. This finding may have implications for pulmonary adenocarcinoma development in humans, since Ki-ras oncogenes are detected in 35% of this human tumor type.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352876      PMCID: PMC402106          DOI: 10.1073/pnas.89.13.5804

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Lung tumors in mice: application to carcinogenesis bioassay.

Authors:  M B Shimkin; G D Stoner
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

Review 2.  Genetic and epigenetic losses of heterozygosity in cancer predisposition and progression.

Authors:  H J Scrable; C Sapienza; W K Cavenee
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

3.  Genome imprinting, cellular mosaicism and carcinogenesis.

Authors:  C Sapienza
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

4.  DNA sequence polymorphisms in Alu repeats.

Authors:  M Orita; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

5.  Structural and functional characterization of the promoter region of the mouse c-Ki-ras gene.

Authors:  E K Hoffman; S P Trusko; N Freeman; D L George
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

6.  An S1 nuclease-sensitive homopurine/homopyrimidine domain in the c-Ki-ras promoter interacts with a nuclear factor.

Authors:  E K Hoffman; S P Trusko; M Murphy; D L George
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 7.  ras oncogenes in human cancer: a review.

Authors:  J L Bos
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

8.  Molecular analysis of spontaneous mutations at the gpt locus in Chinese hamster ovary (AS52) cells.

Authors:  K R Tindall; L F Stankowski
Journal:  Mutat Res       Date:  1989 Mar-May       Impact factor: 2.433

9.  Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse.

Authors:  T R Devereux; M W Anderson; S A Belinsky
Journal:  Carcinogenesis       Date:  1991-02       Impact factor: 4.944

10.  Activated protooncogenes in human lung tumors from smokers.

Authors:  S H Reynolds; C K Anna; K C Brown; J S Wiest; E J Beattie; R W Pero; J D Iglehart; M W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

View more
  14 in total

1.  RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.

Authors:  Jie Li; Zhongqiu Zhang; Zunyan Dai; Anthony P Popkie; Christoph Plass; Carl Morrison; Yian Wang; Ming You
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

2.  A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice.

Authors:  Minh D To; Jesus Perez-Losada; Jian-Hua Mao; Jeff Hsu; Tyler Jacks; Allan Balmain
Journal:  Nat Genet       Date:  2006-07-02       Impact factor: 38.330

Review 3.  Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer.

Authors:  Nobuko Wakamatsu; Theodora R Devereux; Hue-Hua L Hong; Robert C Sills
Journal:  Toxicol Pathol       Date:  2007-01       Impact factor: 1.902

4.  LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer.

Authors:  Jie Li; Zhongqiu Zhang; Zunyan Dai; Christoph Plass; Carl Morrison; Yian Wang; Jonathan S Wiest; Marshall W Anderson; Ming You
Journal:  Oncogene       Date:  2003-02-27       Impact factor: 9.867

5.  The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility.

Authors:  B Chen; L Johanson; J S Wiest; M W Anderson; M You
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.

Authors:  R S Cha; W G Thilly; H Zarbl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19.

Authors:  T R Devereux; R W Wiseman; N Kaplan; S Garren; J F Foley; C M White; C Anna; M A Watson; A Patel; S Jarchow
Journal:  Mamm Genome       Date:  1994-12       Impact factor: 2.957

Review 8.  The Kras2 oncogene and mouse lung carcinogenesis.

Authors:  Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

9.  Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.

Authors:  Shigehisa Yanagi; Hiroyuki Kishimoto; Kohichi Kawahara; Takehiko Sasaki; Masato Sasaki; Miki Nishio; Nobuyuki Yajima; Koichi Hamada; Yasuo Horie; Hiroshi Kubo; Jeffrey A Whitsett; Tak Wah Mak; Toru Nakano; Masamitsu Nakazato; Akira Suzuki
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer.

Authors:  S A Belinsky; K J Nikula; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.